CDH2 encodes the N-cadherin protein, and the previous study has confirmed that the expression of CDH2 in patients with high-grade glioma is higher than that in patients with LGG, and patients with high expression of CDH2 show poor prognosis (30). The gene discussed is CDH2; the disease is central nervous system cancer.